Scanbio Denmark ApS: Financial statements 2024
CVR: 42107654
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 16,399,410 and a net result of DKK 1,999,265 compared with DKK 4,013,557 the year before. That is an increase of 47.1% compared with the year before. Equity in the 2024 report amounted to DKK 10,385,067. The solvency ratio was 35.1%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 16,399,410
- Profit/Loss
- DKK 1,999,265
- Equity
- DKK 10,385,067
- Total Assets
- DKK 29,559,856
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 16.4 mio. | 2 mio. | 10.4 mio. | 4 |
| 2023 | - | 11.2 mio. | 4 mio. | 8.4 mio. | 4 |
| 2022 | - | 8.1 mio. | 3.9 mio. | 4.4 mio. | 4 |
| 2021 | - | 2.5 mio. | 448 t. | 488 t. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Scanbio Denmark ApS has published its annual report for 2023. Gross profit came to DKK 11,150,985, and the net result was DKK 4,013,557.
About Scanbio Denmark ApS
Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity in the 2025 report amounted to DKK 10,249,140.